NCT00560144View on ClinicalTrials.gov

A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors.

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Neoplasms
Interventions
DRUG

RG1507

3mg/kg iv weekly

DRUG

RG1507

9mg/kg iv weekly

DRUG

RG1507

Pharmacokinetic-derived dose, \<=16mg/kg iv weekly

Trial Locations (6)

10017

New York

19104

Philadelphia

20982

Bethesda

77030

Houston

80218

Denver

85724

Tucson

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00560144 - A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors. | Biotech Hunter | Biotech Hunter